The calcium activated nucleotidases: A diverse family of soluble and membrane associated nucleotide hydrolyzing enzymes

Purinergic Signalling

Volumn 2, Issue 2, 2006, Pages 327-333

  Smith, Thomas M ^a   Kirley, Terence L ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apyrase; Blood feeding insects; Calcium; Nucleotidase; Site directed mutagenesis; Structural determination

Indexed keywords

EID: 33748759937     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-005-5300-7     Document Type: Review

References (37)

1. Cheeseman MT. Characterization of apyrase activity from the salivary glands of the cat flea Ctenocephalides felis. Insect Biochem. Mol. Biol. 1998; 28: 1025-30.
2. Mans BJ, Gaspar AR, Louw AI et al. Apyrase activity and platelet aggregation inhibitors in the tick Ornithodoros savignyi (Acari: Argasidae). Exp Appl Acarol 1998; 22: 353-56.
3. Perez de Leon AA, Tabachnick WJ. Apyrase activity and adenosine diphosphate induced platelet aggregation inhibition by the salivary gland proteins of Culicoides variipennis, the North American vector of bluetongue viruses. Vet Parasitol 1996; 61: 327-38.
4. Charlab R, Valenzuela JG, Rowton ED et al. Toward an understanding of the biochemical and pharmacological complexity of the saliva of a hematophagous sand fly Lutzomyia longipalpis. Proc Natl Acad Sci USA 1999; 96: 15155-60.
5. Valenzuela JG, Belkaid Y, Rowton E et al. The salivary apyrase of the blood-sucking sand fly Phlebotomus papatasi belongs to the novel Cimex family of apyrases. J Exp Biol 2001; 204: 229-37.
6. Basanova AV, Baskova IP, Zavalova LL. Vascular-platelet and plasma hemostasis regulators from bloodsucking animals. Biochemistry (Mosc) 2002; 67: 143-50.
7. Champagne DE. Antihemostatic strategies of blood-feeding arthropods. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4: 375-96.
8. Ribeiro JM, Francischetti IM. Role of arthropod saliva in blood feeding: Sialome and post-sialome perspectives. Annu Rev Entomol 2003; 48: 73-88.
9. Valenzuela JG, Charlab R, Galperin MY et al. Purification, cloning, and expression of an apyrase from the bed bug Cimex lectularius. A new type of nucleotide-binding enzyme. J Biol Chem 1998; 273: 30583-90.
10. Kunapuli SP. P2 receptors and platelet activation. Sci World J 2002; 2: 424-33.
11. Murugappan S, Shankar H, Kunapuli SP. Platelet receptors for adenine nucleotides and thromboxane A2. Semin Thromb Hemost 2004; 30: 411-8.
12. Benoit P, Dogne JM. Platelet ADP receptors and their antagonists. Mini Rev Med Chem 2003; 3: 145-8.
13. Hechler B, Cattaneo M, Gachet C. The P2 receptors in platelet function. Semin Thromb Hemost 2005; 31: 150-61.
14. Failer BU, Braun N, Zimmermann H. Cloning, expression, and functional characterization of a Ca(2+)-dependent endoplasmic reticulum nucleoside diphosphatase. J Biol Chem 2002; 277: 36978-86.
15. Handa M, Guidotti G. Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum). Biochem Biophys Res Commun 1996; 218: 916-23.
16. Smith TM, Hicks-Berger CA, Kim S et al. Cloning, expression, and characterization of a soluble calcium-activated nucleotidase, a human enzyme belonging to a new family of extracellular nucleotidases. Arch Biochem Biophys 2002; 406: 105-15.
17. Murphy DM, Ivanenkov VV, Kirley TL. Bacterial expression and characterization of a novel, soluble, calcium-binding, and calcium-activated human nucleotidase. Biochemistry 2003; 42: 2412-21.
18. Yang M, Kirley TL. Site-directed mutagenesis of human soluble calcium-activated nucleotidase 1 (hSCAN-1): Identification of residues essential for enzyme activity and the Ca(2+)-induced conformational change. Biochemistry 2004; 43: 9185-94.
19. Murphy-Piedmonte DM, Crawford PA, Kirley TL. Bacterial expression, folding, purification and characterization of soluble NTPDase5 (CD39L4) ecto-nucleotidase. Biochim Biophys Acta 2005; 1747: 251-9.
20. Dai J, Liu J, Deng Y et al. Structure and protein design of a human platelet function inhibitor. Cell 2004; 116: 649-59.
21. Mans BJ, Coetzee J, Louw AI et al. Disaggregation of aggregated platelets by apyrase from the tick, Ornithodoros savignyi (Acari: Argasidae). Exp Appl Acarol 2000; 24: 271-82.
22. Ulrichts H, Vanhoorelbeke K, Van De Walle G et al. New approaches for antithrombotic antiplatelet therapies. Curr Med Chem 2004; 11: 2261-3.
23. Bhatt DL, Topol EJ. Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2003; 2: 15-28.
24. Jackson SP, Schoenwaelder SM. Antiplatelet therapy: In search of the 'magic bullet'. Nat Rev Drug Discov 2003; 2: 775-89.
25. Robson SC, Wu Y, Sun X et al. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 2005; 31: 217-33.
26. Dwyer KM, Robson SC, Nandurkar HH et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004; 113: 1440-6.
27. Qawi I, Robson SC. New developments in anti-platelet therapies: Potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. Curr Drug Targets 2000; 1: 285-96.
28. Marcus AJ, Broekman MJ, Drosopoulos JH et al. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 2005; 31: 234-46.
29. Marcus AJ, Broekman MJ, Drosopoulos JH et al. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ ecto-nucleotidase-1: Implications for ischemic vascular diseases. J Pharmacol Exp Ther 2003; 305: 9-16.
30. Weksler BB. Antiplatelet agents in stroke prevention. Combination therapy: Present and future. Cerebrovasc Dis 2000; 10 Suppl 5: 41-8.
31. Pinsky DJ, Broekman MJ, Peschon JJ et al. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 2002; 109: 1031-40.
32. Belayev L, Khoutorova L, Deisher TA et al. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke 2003; 34: 758-63.
33. Costa AF, Gamermann PW, Picon PX et al. Intravenous apyrase administration reduces arterial thrombosis in a rabbit model of endothelial denudation in vivo. Blood Coagul Fibrinolysis 2004; 15: 545-51.
34. Guckelberger O, Sun XF, Sevigny J et al. Beneficial effects of CD39/ ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Thromb Haemost 2004; 91: 576-86.
35. Gangadharan SP, Imai M, Rhynhart KK et al. Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries. Surgery 2001; 130: 296-303.
36. Imai M, Takigami K, Guckelberger O et al. Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation 2000; 70: 864-70.
37. Imai M, Takigami K, Guckelberger O et al. CD39/vascular ATP diphosphohydrolase modulates xenograft survival. Transplant Proc 2000; 32: 969.